# Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)

> **NCT00868465** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 600 (estimated)

## Conditions studied

- Uncomplicated Malaria

## Interventions

- **DRUG:** Artemether-Lumefantrine
- **DRUG:** Dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT00868465
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2010-06-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868465, "Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00868465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*